These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

916 related articles for article (PubMed ID: 22634756)

  • 1. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators.
    Fujimoto A; Totoki Y; Abe T; Boroevich KA; Hosoda F; Nguyen HH; Aoki M; Hosono N; Kubo M; Miya F; Arai Y; Takahashi H; Shirakihara T; Nagasaki M; Shibuya T; Nakano K; Watanabe-Makino K; Tanaka H; Nakamura H; Kusuda J; Ojima H; Shimada K; Okusaka T; Ueno M; Shigekawa Y; Kawakami Y; Arihiro K; Ohdan H; Gotoh K; Ishikawa O; Ariizumi S; Yamamoto M; Yamada T; Chayama K; Kosuge T; Yamaue H; Kamatani N; Miyano S; Nakagama H; Nakamura Y; Tsunoda T; Shibata T; Nakagawa H
    Nat Genet; 2012 May; 44(7):760-4. PubMed ID: 22634756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
    Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
    J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Patterns of HBV Integration and
    Jang JW; Kim HS; Kim JS; Lee SK; Han JW; Sung PS; Bae SH; Choi JY; Yoon SK; Han DJ; Kim TM; Roberts LR
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.
    Yang X; Guo X; Chen Y; Chen G; Ma Y; Huang K; Zhang Y; Zhao Q; Winkler CA; An P; Lyu J
    Oncotarget; 2016 May; 7(19):27838-47. PubMed ID: 27056898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma.
    Sze KM; Ho DW; Chiu YT; Tsui YM; Chan LK; Lee JM; Chok KS; Chan AC; Tang CN; Tang VW; Lo IL; Yau DT; Cheung TT; Ng IO
    Hepatology; 2021 Jan; 73(1):23-40. PubMed ID: 32170761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Hepatitis B Virus Integrations Identified in Hepatocellular Carcinoma Genomes.
    Mathkar PP; Chen X; Sulovari A; Li D
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TERT promoter mutation in resectable hepatocellular carcinomas: a strong association with hepatitis C infection and absence of hepatitis B infection.
    Chen YL; Jeng YM; Chang CN; Lee HJ; Hsu HC; Lai PL; Yuan RH
    Int J Surg; 2014; 12(7):659-65. PubMed ID: 24866078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
    Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach.
    Ding D; Lou X; Hua D; Yu W; Li L; Wang J; Gao F; Zhao N; Ren G; Li L; Lin B
    PLoS Genet; 2012; 8(12):e1003065. PubMed ID: 23236287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic landscape influences the liver cancer genome architecture.
    Hama N; Totoki Y; Miura F; Tatsuno K; Saito-Adachi M; Nakamura H; Arai Y; Hosoda F; Urushidate T; Ohashi S; Mukai W; Hiraoka N; Aburatani H; Ito T; Shibata T
    Nat Commun; 2018 Apr; 9(1):1643. PubMed ID: 29691395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma.
    Pezzuto F; Izzo F; Buonaguro L; Annunziata C; Tatangelo F; Botti G; Buonaguro FM; Tornesello ML
    Oncotarget; 2016 Aug; 7(34):54253-54262. PubMed ID: 27276713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive genome sequencing of the liver cancer genome.
    Nakagawa H; Shibata T
    Cancer Lett; 2013 Nov; 340(2):234-40. PubMed ID: 23142287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.
    Toh ST; Jin Y; Liu L; Wang J; Babrzadeh F; Gharizadeh B; Ronaghi M; Toh HC; Chow PK; Chung AY; Ooi LL; Lee CG
    Carcinogenesis; 2013 Apr; 34(4):787-98. PubMed ID: 23276797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas.
    Murakami Y; Saigo K; Takashima H; Minami M; Okanoue T; Bréchot C; Paterlini-Bréchot P
    Gut; 2005 Aug; 54(8):1162-8. PubMed ID: 16009689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
    Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
    Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of HBV Genomes Integrated into the Genomes of Human Hepatoma PLC/PRF/5 Cells by HBV Sequence Capture-Based Next-Generation Sequencing.
    Ishii T; Tamura A; Shibata T; Kuroda K; Kanda T; Sugiyama M; Mizokami M; Moriyama M
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32570699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.
    Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H
    Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.
    Sung WK; Zheng H; Li S; Chen R; Liu X; Li Y; Lee NP; Lee WH; Ariyaratne PN; Tennakoon C; Mulawadi FH; Wong KF; Liu AM; Poon RT; Fan ST; Chan KL; Gong Z; Hu Y; Lin Z; Wang G; Zhang Q; Barber TD; Chou WC; Aggarwal A; Hao K; Zhou W; Zhang C; Hardwick J; Buser C; Xu J; Kan Z; Dai H; Mao M; Reinhard C; Wang J; Luk JM
    Nat Genet; 2012 May; 44(7):765-9. PubMed ID: 22634754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
    Ki Kim S; Ueda Y; Hatano E; Kakiuchi N; Takeda H; Goto T; Shimizu T; Yoshida K; Ikura Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Uemoto S; Chiba T; Ogawa S; Marusawa H
    Int J Cancer; 2016 Dec; 139(11):2512-8. PubMed ID: 27511114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.